An intensive treatment strategy of rapid up-titration of guideline-directed medication
and close follow-up after an acute heart failure admission was readily accepted by
patients because it reduced symptoms, improved quality of life, and reduced the risk
of 180-day all-cause death or heart failure readmission compared with usual care.